ConductScience.org, home

Paper33808293

Proof-of-Concept Study of Multifunctional Hybrid Nanoparticle System Combined with NIR Laser Irradiation for the Treatment of Melanoma.

Lopes J and 11 others. Biomolecules, 2021. Cited by 26 papers, by iCite.

Cite this record

ConductScience Library. Proof-of-Concept Study of Multifunctional Hybrid Nanoparticle System Combined with NIR Laser Irradiation for the Treatment of Melanoma. Papers, record 33808293. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33808293

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Proof-of-Concept Study of Multifunctional Hybrid Nanoparticle System Combined with NIR Laser Irradiation for the Treatment of Melanoma.
PubMed
Journal
Biomolecules
PubMed
Year
2021
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
26
iCite
Relative citation ratio, by iCite
2.09
iCite
Revised in PubMed
2024-02-26
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lopes JJoanahttps://orcid.org/0000-0002-0307-3040
2Ferreira-Gonçalves TTâniahttps://orcid.org/0000-0001-9916-3907
3Figueiredo IVIsabel V
4Rodrigues CMPCecília M Phttps://orcid.org/0000-0002-4829-754X
5Ferreira HHugo
6Ferreira DDavidhttps://orcid.org/0000-0002-9720-3140
7Viana ASAna S
8Faísca PPedro
9Gaspar MMMaria Manuelahttps://orcid.org/0000-0001-6814-7226
10Coelho JMPJoão M Phttps://orcid.org/0000-0002-4339-0550
11Silva COCatarina Oliveirahttps://orcid.org/0000-0002-5077-5176
12Reis CPCatarina Pintohttps://orcid.org/0000-0002-1046-4031

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Low-Level Light TherapyMajor topic
MelanomaMajor topic
Multifunctional NanoparticlesMajor topic
Skin NeoplasmsMajor topic
Animals
Cell Line, Tumor
Epidermal Growth Factor
Gold
Humans
Male
Metal Nanoparticles
Mice, SCID
Oleic Acid
Proof of Concept Study
Xenograft Model Antitumor Assays
Mice

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
SFRH/BD/148044/2019 and SFRH/BD/147306/2019FCTPubMed
PTDC/BBB-BMC/0611/2012, 551 UIDB/00645/2020, UIDB/04138/2020 and UIDP/04138/2020FCTPubMed

Source PubMed

Download CSV of grants

References64

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
133353068A Step Forward in Breast Cancer Research: From a Natural-Like Experimental Model to a Preliminary Photothermal Approach.Int J Mol Sci2020https://conductscience.org/library/papers/33353068PubMed
220679910Metastasis in an orthotopic murine model of melanoma is independent of RAS/RAF mutation.Melanoma Res2010https://conductscience.org/library/papers/20679910PubMed
319891496RGD-conjugated dendrimer-modified gold nanorods for in vivo tumor targeting and photothermal therapy.Mol Pharm2010https://conductscience.org/library/papers/19891496PubMed
428223185Nanomedicine as a potent strategy in melanoma tumor microenvironment.Pharmacol Res2017https://conductscience.org/library/papers/28223185PubMed
527788212EGF Functionalized Polymer-Coated Gold Nanoparticles Promote EGF Photostability and EGFR Internalization for Photothermal Therapy.PLoS One2016https://conductscience.org/library/papers/27788212PubMed
619447870Immunodeficient mouse strains display marked variability in growth of human melanoma lung metastases.Clin Cancer Res2009https://conductscience.org/library/papers/19447870PubMed
79219503Human tumor models in the severe combined immune deficient (scid) mouse.Cancer Chemother Pharmacol1997https://conductscience.org/library/papers/9219503PubMed
829562135Cellular Uptake of Gold Nanoparticles Triggered by Host-Guest Interactions.J Am Chem Soc2018https://conductscience.org/library/papers/29562135PubMed
931931389Size-dependent apoptotic activity of gold nanoparticles on osteosarcoma cells correlated with SERS signal.J Photochem Photobiol B2020https://conductscience.org/library/papers/31931389PubMed
1026884153Tailoring nanoparticle designs to target cancer based on tumor pathophysiology.Proc Natl Acad Sci U S A2016https://conductscience.org/library/papers/26884153PubMed
1119052619Efficient tumour formation by single human melanoma cells.Nature2008https://conductscience.org/library/papers/19052619PubMed
1227125352From melanocytes to melanomas.Nat Rev Cancer2016https://conductscience.org/library/papers/27125352PubMed
1323089470Preclinical evaluation of the antimetastatic efficacy of Pentoxifylline on A375 human melanoma cell line.Biomed Pharmacother2012https://conductscience.org/library/papers/23089470PubMed
1426451914In Vitro and In Vivo Tumor Targeted Photothermal Cancer Therapy Using Functionalized Graphene Nanoparticles.Biomacromolecules2015https://conductscience.org/library/papers/26451914PubMed
1522993143Genetically engineered cancer models, but not xenografts, faithfully predict anticancer drug exposure in melanoma tumors.Oncologist2012https://conductscience.org/library/papers/22993143PubMed
1628426435Surface plasmon resonance in gold nanoparticles: a review.J Phys Condens Matter2017https://conductscience.org/library/papers/28426435PubMed
1731753105Epidemiology and Risk Factors of Melanoma.Surg Clin North Am2020https://conductscience.org/library/papers/31753105PubMed
1812438452Modulation of tumor growth by inhibitory Fc(gamma) receptor expressed by human melanoma cells.J Clin Invest2002https://conductscience.org/library/papers/12438452PubMed
1928078340Biocompatible CuS-based nanoplatforms for efficient photothermal therapy and chemotherapy in vivo.Biomater Sci2017https://conductscience.org/library/papers/28078340PubMed
2031694306Development and Mechanistic Insight into the Enhanced Cytotoxic Potential of Parvifloron D Albumin Nanoparticles in EGFR-Overexpressing Pancreatic Cancer Cells.Cancers (Basel)2019https://conductscience.org/library/papers/31694306PubMed

See all 64 referencesDownload CSV of references

Cited by21

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.

PMIDTitleJournalYearIn PapersSource
42926737Targeted photodynamic therapy for colorectal cancer using antibody-conjugated green-synthesised nanoparticles.Discov Oncol2026https://conductscience.org/library/papers/42926737PubMed
42794589Overcoming Biophysical Barriers in Melanoma Photomedicine: From Photodynamic Therapy to Smart Nanodelivery and Photoimmunotherapy.Int J Mol Sci2026https://conductscience.org/library/papers/42794589PubMed
42511737Photodynamic Therapy for Keratinocytic Precancerous Lesions and Non-Melanoma Skin Cancer: A Narrative Review.Int J Mol Sci2026https://conductscience.org/library/papers/42511737PubMed
42428967Gold Nanoplatforms for Phenotypic Reprogramming and Closed-Loop Theranostics of Cancer Stem Cells.Int J Nanomedicine2026https://conductscience.org/library/papers/42428967PubMed
39940134Surface Functionalization of Nanocarriers with Anti-EGFR Ligands for Cancer Active Targeting.Nanomaterials (Basel)2025https://conductscience.org/library/papers/39940134PubMed
39833557Recent advances in improved efficacies of gold nano-formulations in treatment of skin cancer: a systematic review.Arch Dermatol Res2025https://conductscience.org/library/papers/39833557PubMed
39314189Targeting superficial cancers with gold nanoparticles: a review of current research.Ther Deliv2024https://conductscience.org/library/papers/39314189PubMed
39065597Enhanced Cytotoxicity against a Pancreatic Cancer Cell Line Combining Radiation and Gold Nanoparticles.Pharmaceutics2024https://conductscience.org/library/papers/39065597PubMed
38674073A Step Forward for the Treatment of Localized Prostate Cancer Using Gold Nanoparticles Combined with Laser Irradiation.Int J Mol Sci2024https://conductscience.org/library/papers/38674073PubMed
37111608Safety of Gold Nanoparticles: From In Vitro to In Vivo Testing Array Checklist.Pharmaceutics2023https://conductscience.org/library/papers/37111608PubMed
36722207Photobiomodulation: A Systematic Review of the Oncologic Safety of Low-Level Light Therapy for Aesthetic Skin Rejuvenation.Aesthet Surg J2023https://conductscience.org/library/papers/36722207PubMed
36635761Advancements in nanoparticle-based treatment approaches for skin cancer therapy.Mol Cancer2023https://conductscience.org/library/papers/36635761PubMed
36551565Current Insights and Progress in the Clinical Management of Head and Neck Cancer.Cancers (Basel)2022https://conductscience.org/library/papers/36551565PubMed
36230575Melanoma Management: From Epidemiology to Treatment and Latest Advances.Cancers (Basel)2022https://conductscience.org/library/papers/36230575PubMed
36145569How to Treat Melanoma? The Current Status of Innovative Nanotechnological Strategies and the Role of Minimally Invasive Approaches like PTT and PDT.Pharmaceutics2022https://conductscience.org/library/papers/36145569PubMed
36005086Biological Thermal Performance of Organic and Inorganic Aerogels as Patches for Photothermal Therapy.Gels2022https://conductscience.org/library/papers/36005086PubMed
35547773Advanced nanocarrier- and microneedle-based transdermal drug delivery strategies for skin diseases treatment.Theranostics2022https://conductscience.org/library/papers/35547773PubMed
35053219The Role of Rosmarinic Acid on the Bioproduction of Gold Nanoparticles as Part of a Photothermal Approach for Breast Cancer Treatment.Biomolecules2022https://conductscience.org/library/papers/35053219PubMed
34924904An update of advanced nanoplatforms for Glioblastoma Multiforme Management.EXCLI J2021https://conductscience.org/library/papers/34924904PubMed
34831311The Challenging Melanoma Landscape: From Early Drug Discovery to Clinical Approval.Cells2021https://conductscience.org/library/papers/34831311PubMed

See all 21 cited byDownload CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD44960PubTator's text mininghttps://conductscience.org/library/genes/960NCBI Gene
EGF1950PubTator's text mininghttps://conductscience.org/library/genes/1950NCBI Gene
EGFR1956PubTator's text mininghttps://conductscience.org/library/genes/1956NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33808293

GET https://conductscience.org/api/papers/v1/33808293/references?page=2